rs369221781
Variant summary
Our verdict is Likely benign. The variant received -3 ACMG points: 1P and 4B. PP2BP4_Strong
The NM_005518.4(HMGCS2):c.71C>T(p.Thr24Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000108 in 1,613,958 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_005518.4 missense
Scores
Clinical Significance
Conservation
Publications
- 3-hydroxy-3-methylglutaryl-CoA synthase deficiencyInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Orphanet, ClinGen, G2P
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HMGCS2 | NM_005518.4 | c.71C>T | p.Thr24Ile | missense_variant | Exon 1 of 10 | ENST00000369406.8 | NP_005509.1 | |
HMGCS2 | NM_001166107.1 | c.71C>T | p.Thr24Ile | missense_variant | Exon 1 of 9 | NP_001159579.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000788 AC: 12AN: 152206Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000518 AC: 13AN: 251120 AF XY: 0.0000589 show subpopulations
GnomAD4 exome AF: 0.000111 AC: 162AN: 1461752Hom.: 0 Cov.: 31 AF XY: 0.0000880 AC XY: 64AN XY: 727194 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000788 AC: 12AN: 152206Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74362 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
3-hydroxy-3-methylglutaryl-CoA synthase deficiency Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has not been reported in the literature in individuals with HMGCS2-related disease. This variant is present in population databases (rs369221781, ExAC 0.02%). This sequence change replaces threonine with isoleucine at codon 24 of the HMGCS2 protein (p.Thr24Ile). The threonine residue is weakly conserved and there is a moderate physicochemical difference between threonine and isoleucine. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at